The impact of age on outcome of embryonal and alveolar rhabdomyosarcoma patients. A multicenter study

Anticancer Research

Volumn 32, Issue 10, 2012, Pages 4485-4498

  Van Gaal, Jorieke C ^a,b,c   Van Der Graaf, Winette T A ^c   Rikhof, Bart ^a   Van Hoesel, Quirinis G C M ^c   Teerenstra, Steven ^c   Suurmeijer, Albert J H ^a   Flucke, Uta E ^c   Loeffen, Jan L C M ^c   Sleijfer, Stefan ^d   De Bont, Eveline S J M ^b  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

^c RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Adolescents; Adults; Age; Outcome; Prognostic factor; Rhabdomyosarcoma; Treatment

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; IFOSFAMIDE; VINCRISTINE;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CANCER PROGNOSIS; CHILD; DISEASE FREE SURVIVAL; EMBRYONAL RHABDOMYOSARCOMA; FEMALE; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEWBORN; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RHABDOMYOSARCOMA; SCHOOL CHILD;

ADOLESCENT; ADULT; AGE FACTORS; AGED; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFANT; MALE; MIDDLE AGED; PROGNOSIS; RETROSPECTIVE STUDIES; RHABDOMYOSARCOMA, ALVEOLAR; RHABDOMYOSARCOMA, EMBRYONAL; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84867770954     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. Gurney JG, Young JL, Roffers SD, Smith MA and Bunin GR: Soft tissue sarcomas. In: Cancer Incidence and Survival Among Children and Adolescents: United States SEER Program, 1975-1995. Ries LAG, Smith MA, Gurney JG, Linet M, Tamra T, Young JL and Bunin GR (eds.) Bethesda, MD: National Cancer Institute SEER Program. NIH Pub No. 99-4649: 111-123, 1999.
2. Arndt CA and Crist WM: Common musculoskeletal tumors of childhood and adolescence. N Engl J Med 341: 342-352, 1999.
3. Bleyer A, O'Leary M, Barr R and Ries LAG (eds.): Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, including SEER Incidence and Survival: 1975-2000. National Cancer Institute, NIH Pub. No. 06-5767. Bethesda, MD, 2006.
4. Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A, Miller BA, Lewis DR, Eisner MP, Stinchcomb DG, Edwards BK (eds.): SEER Cancer Statistics Review, 1975-2006, National Cancer Institute, based on November 2008 SEER data submission, Bethesda, MD, 2009.
5. Maurer HM, Beltangady M, Gehan EA, Crist W, Hammond D, Hays DM, Heyn R, Lawrence W, Newton W and Ortega J: The Intergroup Rhabdomyosarcoma Study-I. A final report. Cancer 61: 209-220, 1988. (Pubitemid 18056471)
6. Maurer HM, Gehan EA, Beltangady M, Crist W, Dickman PS, Donaldson SS, Fryer C, Hammond D, Hays DM and Herrmann J: The Intergroup Rhabdomyosarcoma Study-II. Cancer 71: 1904-1922, 1993. (Pubitemid 23067412)
7. Crist W, Gehan EA, Ragab AH, Dickman PS, Donaldson SS, Fryer C, Hammond D, Hays DM, Herrmann J and Heyn R: The Third Intergroup Rhabdomyosarcoma Study. J Clin Oncol 13: 610-630, 1995.
8. Crist WM, Anderson JR, Meza JL, Fryer C, Raney RB, Ruymann FB, Breneman J, Qualman SJ, Wiener E, Wharam M, Lobe T, Webber B, Maurer HM and Donaldson SS: Intergroup Rhabdomyosarcoma Study-IV: Results for patients with nonmetastatic disease. J Clin Oncol 19: 3091-3102, 2001. (Pubitemid 32567502)
9. Stiller CA: Centralisation of treatment and survival rates for cancer. Arch Dis Child 63: 23-30, 1988.
10. Little DJ, Ballo MT, Zagars GK, Pisters PW, Patel SR, El-Naggar AK, Garden AS and Benjamin RS: Adult rhabdomyosarcoma: outcome following multimodality treatment. Cancer 95: 377-388, 2002. (Pubitemid 34787604)
11. Ferrari A, Dileo P, Casanova M, Bertulli R, Meazza C, Gandola L, Navarria P, Collini P, Gronchi A, Olmi P, Fossati-Bellani F and Casali PG: Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution. Cancer 98: 571-580, 2003. (Pubitemid 36885998)
12. Sultan I, Qaddoumi I, Yaser S, Rodriguez-Galindo C and Ferrari A: Comparing adult and pediatric rhabdomyosarcoma in the surveillance, epidemiology and end results program, 1973 to 2005: an analysis of 2,600 patients. J Clin Oncol 27: 3391-3397, 2009.
13. Flamant F, Rodary C, Rey A, Praquin MT, Sommelet D, Quintana E, Theobald S, Brunat-Mentigny M, Otten J, Voute PA, Habrand JL, Martelli H, Barrett A, Terrier-Lacombe MJ and Oberlin O: Treatment of non-metastatic rhabdomyosarcomas in childhood and adolescence. Results of the second study of the International Society of Paediatric Oncology: MMT84. Eur J Cancer 34: 1050-1062, 1998. (Pubitemid 28308346)
14. Newton WA Jr., Gehan EA, Webber BL, Marsden HB, van Unnik AJ, Hamoudi AB, Tsokos MG, Shimada H, Harms D and Schmidt D: Classification of rhabdomyosarcomas and related sarcomas. Pathologic aspects and proposal for a new classification-an Intergroup Rhabdomyosarcoma Study. Cancer 76: 1073-1085, 1995.
15. Rodary C, Rey A, Olive D, Flamant F, Quintana E, Brunat-Mentigny M, Otten J, and Voute PA: Prognostic factors in 281 children with nonmetastatic rhabdomyosarcoma (RMS) at diagnosis. Med Pediatr Oncol 16: 71-77, 1988.
16. Joshi D, Anderson JR, Paidas C, Breneman J, Parham DM and Crist W: Age is an independent prognostic factor in rhabdomyosarcoma: A report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. Pediatr Blood Cancer 42: 64-73, 2004. (Pubitemid 38173459)
17. Crist WM, Garnsey L, Beltangady MS, Gehan E, Ruymann F, Webber B, Hays DM, Wharam M and Maurer HM: Prognosis in children with rhabdomyosarcoma: A report of the Intergroup Rhabdomyosarcoma Studies I and II. Intergroup Rhabdomyosarcoma Committee. J Clin Oncol 8: 443-452, 1990. (Pubitemid 20087545)
18. Simon JH, Paulino AC, Ritchie JM, Mayr NA and Buatti JM: Presentation, prognostic factors and patterns of failure in adult rhabdomyosarcoma. Sarcoma 7: 1-7, 2003. (Pubitemid 36577840)
19. Lloyd RV, Hajdu SI and Knapper WH: Embryonal rhabdomyosarcoma in adults. Cancer 51: 557-565, 1983. (Pubitemid 13185391)
20. Prestidge BR and Donaldson SS: Treatment results among adults with childhood tumors: a 20-year experience. Int J Radiat Oncol Biol Phys 17: 507-514, 1989. (Pubitemid 19227553)
21. Kattan J, Culine S, Terrier-Lacombe MJ, Theodore C and Droz JP: Paratesticular rhabdomyosarcoma in adult patients: 16-year experience at Institut Gustave-Roussy. Ann Oncol 4: 871-875, 1993. (Pubitemid 24032095)
22. Laquaglia MP, Ghavimi F, Penenberg D, Mandell LR, Healey JH, Hadju SI and Exelby PR: Factors predictive of mortality in pediatric extremity rhabdomyosarcoma. J Pediatr Surg 25: 238-243, 1990.
23. Lawrence W, Jr., Anderson JR, Gehan EA and Maurer H: Pretreatment TNM staging of childhood rhabdomyosarcoma: A report of the Intergroup Rhabdomyosarcoma Study Group. Children's Cancer Study Group. Pediatric Oncology Group. Cancer 80: 1165-1170, 1997. (Pubitemid 27427618)
24. Stevens MC, Rey A, Bouvet N, Ellershaw C, Flamant F, Habrand JL, Marsden HB, Martelli H, Sanchez de Toledo J, Spicer RD, Spooner D, Terrier-Lacombe MJ, van Unnik A and Oberlin O: Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology - SIOP Malignant Mesenchymal Tumor 89. J Clin Oncol 23: 2618-2628, 2005. (Pubitemid 46179450)
25. Orbach D, Rey A, Oberlin O, Sanchez de Toledo J, Terrier-Lacombe MJ, van Unnik A, Quintana E and Stevens MCG: Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the international society of pediatric oncology (SIOP) malignant mesenchymal tumor committee. J Clin Oncol 29: 4363-4371, 2005.
26. Rodeberg DA, Garcia-Henriquez N, Lyden ER, Davicioni E, Parham DM, Skapek SX, Hayes-Jordan AA, Donaldson SS, Brown KL, Triche TJ, Meyer WH and Hawkins DS: Prognostic significance and tumor biology of regional lymph node disease in patients With rhabdomyosarcoma: A Report From the Children's Oncology Group. J Clin Oncol, 2011.
27. Parham DM and Ellison DA: Rhabdomyosarcomas in adults and children: an update. Arch Pathol Lab Med 130: 1454-1465, 2006. (Pubitemid 44520712)
28. Breneman JC, Lyden E, Pappo AS, Link MP, Anderson JR, Parham DM, Qualman SJ, Wharam MD, Donaldson SS, Maurer HM, Meyer WH, Baker KS, Paidas CN and Crist WM: Prognostic factors and clinical outcomes in children and adolescents with metastatic rhabdomyosarcoma: A report from the Intergroup Rhabdomyosarcoma Study IV. J Clin Oncol 21: 78-84, 2003.
29. Carli M, Colombatti R, Oberlin O, Bisogno G, Treuner J, Koscielniak E, Tridello G, Garaventa A, Pinkerton R and Stevens M: European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: Final results and analysis of prognostic factors. J Clin Oncol 22: 4787-4794, 2004.
30. van Gaal JC, de Bont ES, Kaal SE, Versleijen-Jonkers Y, and van der Graaf WT: Building the bridge between rhabdomyosarcoma in children, adolescents and young adults: The road ahead. Crit Rev Oncol Hematol, 2011.
31. Tsokos M, Webber BL, Parham DM, Wesley RA, Miser A, Miser JS, Etcubanas E, Kinsella T, Grayson J and Glatstein E: Rhabdomyosarcoma. A new classification scheme related to prognosis. Arch Pathol Lab Med 116: 847-855, 1992.
32. Reboul-Marty J, Quintana E, Mosseri V, Flamant F, Asselain B, Rodary C and Zucker JM: Prognostic factors of alveolar rhabdomyosarcoma in childhood. An International Society of Pediatric Oncology study. Cancer 68: 493-498, 1991.
33. D'Orazio JA: Inherited cancer syndromes in children and young adults. J Pediatr Hematol Oncol 32: 195-228, 2010.
34. Kelly KM, Womer RB, Sorensen PH, Xiong QB and Barr FG: Common and variant gene fusions predict distinct clinical phenotypes in rhabdomyosarcoma. J Clin Oncol 15: 1831-1836, 1997. (Pubitemid 27209511)
35. Sorensen PH, Lynch JC, Qualman SJ, Tirabosco R, Lim JF, Maurer HM, Bridge JA, Crist WM, Triche TJ and Barr FG: PAX3-FKHR and PAX7-FKHR gene fusions are prognostic indicators in alveolar rhabdomyosarcoma: A report from the Children's Oncology Group. J Clin Oncol 20: 2672-2679, 2002. (Pubitemid 34575640)
36. Stegmaier S, Poremba C, Schaefer KL, Leuschner I, Kazanowska B, Bekassy AN, Bielack SS, Klingebiel T and Koscielniak E: Prognostic value of PAX-FKHR fusion status in alveolar rhabdomyosarcoma: A report from the Cooperative Soft Tissue Sarcoma Study Group (CWS). Pediatr Blood Cancer, 57(3): 406-414, 2011.
37. Komdeur R, Klunder J, van der Graaf WT, van den BE, de Bont ES, Hoekstra HJ and Molenaar WM: Multidrug-resistance proteins in rhabdomyosarcomas: comparison between children and adults. Cancer 97: 1999-2005, 2003.